Published in Scand J Immunol on March 01, 1987
Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes. Immunology (1988) 1.09
Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect Immun (1989) 1.06
Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid. Immunology (1988) 0.96
Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun (1992) 0.95
Studies on the uptake, binding and metabolism of leukotriene B4 by human neutrophils. Immunology (1989) 0.86
Effect of staphylococcal delta-toxin and bee venom peptide melittin on leukotriene induction and metabolism of human polymorphonuclear granulocytes. Infect Immun (1990) 0.79
[A new method for synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide using 1-hydroxybenzotriazoles as additives]. Chem Ber (1970) 3.77
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol (1991) 3.60
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol (1991) 2.72
Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis (1995) 1.97
Complement-dependent B-cell activation by cobra venom factor and other mitogens? J Exp Med (1974) 1.97
Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology (1994) 1.81
Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect Immun (1986) 1.70
Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation. Eur J Immunol (1973) 1.68
Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett (1982) 1.66
Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. J Clin Microbiol (2009) 1.62
Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells. Infect Immun (1985) 1.61
Diagnostic value of high-resolution B-mode and doppler sonography for imaging of hand and finger joints in rheumatoid arthritis. Arthritis Rheum (2003) 1.59
Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol (1991) 1.50
Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Lancet (1997) 1.48
Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom. Immunology (1972) 1.47
Genetic classification and distinguishing of Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. J Clin Microbiol (2008) 1.47
Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549) Clin Exp Allergy (1999) 1.45
DNP-antigens activate the alternate pathway of the complement system. J Immunol (1974) 1.44
Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun (1994) 1.44
[Heavy metal pollution of soil and garden products of Stolberg home gardens and lead and cadmium pollution of small farms in Stolberg]. Gesundheitswesen (1993) 1.39
Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater (2010) 1.34
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Comparative study using various methods for identification of Staphylococcus species in clinical specimens. J Clin Microbiol (2006) 1.33
Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun (1994) 1.32
Generation of leukotrienes from human granulocytes by alveolysin from Bacillus alvei. Infect Immun (1984) 1.30
Arachidonic acid metabolites from polymorphonuclear leukocytes of healthy donors, severely burned patients and children with cystic fibrosis--routine monitoring by high-performance liquid chromatography. J Chromatogr (1988) 1.30
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg (2009) 1.23
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
Comparison of four hemolysin-producing organisms (Escherichia coli, Serratia marcescens, Aeromonas hydrophila, and Listeria monocytogenes) for release of inflammatory mediators from various cells. J Clin Microbiol (1988) 1.19
The neutrophil and leukotrienes--role in health and disease. Eicosanoids (1990) 1.17
Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J Clin Microbiol (2006) 1.17
Rapid ribosequencing--an effective diagnostic tool for detecting microbial infection. Infection (2001) 1.16
Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation. Immunology (1979) 1.16
Subtyping of ST22-MRSA-IV (Barnim epidemic MRSA strain) at a university clinic in Germany from 2002 to 2005. J Med Microbiol (2007) 1.15
Heterogeneity of methicillin-susceptible Staphylococcus aureus strains at a German University Hospital implicates the circulating-strain pool as a potential source of emerging methicillin-resistant S. aureus clones. J Clin Microbiol (2006) 1.14
Generation of leukotrienes and lipoxygenase factors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.14
Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology (1973) 1.13
Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg (1998) 1.12
Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr (2003) 1.10
Factor D in the alternate pathway of complement activation: purification, physicochemical characterization and functional role. Immunochemistry (1974) 1.09
Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes. Immunology (1988) 1.09
Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma (1997) 1.09
Binding of rat IgE with the subcellular components of normal rat mast cells. Immunochemistry (1976) 1.08
Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum (2001) 1.07
Metabolism of leukotrienes by L-gamma-glutamyl-transpeptidase and dipeptidase from human polymorphonuclear granulocytes. Immunology (1985) 1.07
[A new method for the synthesis of peptides: activation of the carboxy group with dicyclohexylcarbodiimide and 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine]. Chem Ber (1970) 1.06
The metabolism of leukotrienes in blood plasma studied by high-performance liquid chromatography. Biochim Biophys Acta (1985) 1.06
Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect Immun (1989) 1.06
Role of Pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes. Infect Immun (1996) 1.06
Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium. J Clin Microbiol (2008) 1.06
Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology (1994) 1.06
Interleukin 6--a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma (1991) 1.05
Signal transduction in human platelets and inflammatory mediator release induced by genetically cloned hemolysin-positive and -negative Escherichia coli strains. Infect Immun (1990) 1.05
[Racemization in peptide syntheses]. Chem Ber (1970) 1.04
Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology (Oxford) (2001) 1.03
Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. Immunology (1989) 1.03
Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid. Eur J Immunol (1978) 1.02
Immunologic properties of mast cells from rats infected with Nippostrongylus brasiliensis. J Immunol (1975) 1.02
Effect of sodium fluoride on the generation of lipoxygenase products from human polymorphonuclear granulocytes, mononuclear cells and platelets--indication for the involvement of G proteins. Immunology (1989) 1.01
Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis (1998) 1.00
Comparison of the performance of the rapid antigen detection actim Influenza A&B test and RT-PCR in different respiratory specimens. J Med Microbiol (2009) 1.00
Induction of inflammatory mediators from human polymorphonuclear granulocytes and rat mast cells by haemolysin-positive and -negative E. coli strains with different adhesins. Immunology (1986) 1.00
Generation of slow-reacting substance (leukotrienes) by endotoxin and lipid A from human polymorphonuclear granulocytes. Immunology (1984) 1.00
The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma. Anticancer Res (1999) 0.98
Specific binding of mouse IgE with rat mast cells. J Immunol (1974) 0.98
Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology (1995) 0.97
Induction and comparison of the eosinophil chemotactic factor with endogenous hydroxyeicosatetraenoic acids: its inhibition by arachidonic acid analogs. Adv Prostaglandin Thromboxane Leukot Res (1982) 0.97
Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid. Immunology (1988) 0.96
Studies on the mechanisms of granulocyte dysfunctions in severely burned patients--evidence for altered leukotriene generation. J Trauma (1989) 0.95
Effects of Listeria monocytogenes and Yersinia enterocolitica on cytokine gene expression and release from human polymorphonuclear granulocytes and epithelial (HEp-2) cells. Infect Immun (1993) 0.95
Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta Biomater (2011) 0.94
Western blot analysis of water-soluble wheat flour (Triticum vulgaris) allergens. Int Arch Allergy Appl Immunol (1990) 0.94
Binding characteristics of aggregated IgGa to rat basophilic leukaemia (RBL) cells and rat mast cells. Immunology (1980) 0.94
Molecular effects of povidone-iodine on relevant microorganisms: an electron-microscopic and biochemical study. Dermatology (1997) 0.93
Atriopeptin III induces endothelium-independent relaxation and increases cGMP levels in rabbit aorta. Klin Wochenschr (1986) 0.93
Composition of staphylococcal bi-component toxins determines pathophysiological reactions. J Med Microbiol (1997) 0.93
Principles of microvascular reconstruction in burn and electrical burn injuries. Burns (2005) 0.93
Pore formation by the Escherichia coli alpha-hemolysin: role for mediator release from human inflammatory cells. Infect Immun (1994) 0.93
Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus. Rheumatology (Oxford) (2001) 0.91
Cytokine-induced (interleukins-3, -6 and -8 and tumour necrosis factor-beta) activation and deactivation of human neutrophils. Immunology (1992) 0.91
Subcellular localization of enzymes involved in leukotriene formation within human polymorphonuclear granulocytes. Immunology (1984) 0.91
IL-8 release from human neutrophils by the respiratory syncytial virus is independent of viral replication. J Leukoc Biol (1996) 0.91